Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis

dc.contributor.authorCarr, Susan J.
dc.contributor.authorWang, Xia
dc.contributor.authorOlavarria, Veronica V.
dc.contributor.authorLavados, Pablo M.
dc.contributor.authorRodriguez, Jorge A.
dc.contributor.authorKim, Jong S.
dc.contributor.authorLee, Tsong-Hai
dc.contributor.authorLindley, Richard
dc.contributor.authorPontes-Neto, Octavio M.
dc.contributor.authorRicci, Stefano
dc.contributor.authorSato, Shoichiro
dc.contributor.authorSharma, Vijay K.
dc.contributor.authorChalmers, John
dc.contributor.authorAnderson, Craig S.
dc.date.accessioned2024-04-04T12:54:29Z
dc.date.available2024-04-04T12:54:29Z
dc.date.issued2017-09
dc.descriptionIndexación: Scopus
dc.description.abstractBackground and Purpose - Renal dysfunction (RD) is associated with poor prognosis after stroke. We assessed the effects of RD on outcomes and interaction with low- versus standard-dose alteplase in a post hoc subgroup analysis of the ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study). Methods - A total of 3220 thrombolysis-eligible patients with acute ischemic stroke (mean age, 66.5 years; 37.8% women) were randomly assigned to low-dose (0.6 mg/kg) or standard-dose (0.9 mg/kg) intravenous alteplase within 4.5 hours of symptom onset. Six hundred and fifty-nine (19.8%) patients had moderate-to-severe RD (estimated glomerular filtration rate, <60 mL/min per 1.73 m2) at baseline. The impact of RD on death or disability (modified Rankin Scale scores, 2-6) at 90 days, and symptomatic intracerebral hemorrhage, was assessed in logistic regression models. Results - Compared with patients with normal renal function (>90 mL/min per 1.73 m2), those with severe RD (<30 mL/min per 1.73 m2) had increased mortality (adjusted odds ratio, 2.07; 95% confidence interval, 0.89-4.82; P=0.04 for trend); every 10 mL/min per 1.73 m2 lower estimated glomerular filtration rate was associated with an adjusted 9% increased odds of death from thrombolysis-treated acute ischemic stroke. There was no significant association with modified Rankin Scale scores 2 to 6 (adjusted odds ratio, 1.03; 95% confidence interval, 0.62-1.70; P=0.81 for trend), modified Rankin Scale 3 to 6 (adjusted odds ratio, 1.20; 95% confidence interval, 0.72-2.01; P=0.44 for trend), or symptomatic intracerebral hemorrhage, or any heterogeneity in comparative treatment effects between low-dose and standard-dose alteplase by RD grades. Conclusions - RD is associated with increased mortality but not disability or symptomatic intracerebral hemorrhage in thrombolysis-eligible and treated acute ischemic stroke patients. Uncertainty persists as to whether low-dose alteplase confers benefits over standard-dose alteplase in acute ischemic stroke patients with RD. © 2017 American Heart Association, Inc.
dc.description.urihttps://www.ahajournals.org/doi/10.1161/STROKEAHA.117.017808
dc.identifier.citationStroke Volume 48, Issue 9, Pages 2605 - 26091 September 2017
dc.identifier.doi10.1161/STROKEAHA.117.017808
dc.identifier.issn0039-2499
dc.identifier.urihttps://repositorio.unab.cl/handle/ria/55637
dc.language.isoen
dc.publisherLippincott Williams and Wilkins
dc.rights.licenseCC BY 4.0 DEED Atribución 4.0 Internacional
dc.subjectglomerular filtration rate
dc.subjecthypertension
dc.subjectintracranial hemorrhages
dc.subjectodds ratio
dc.subjectstroke
dc.titleInfluence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis
dc.typeArtículo
Archivos
Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
TEXTO EN INGLES
Tamaño:
280.05 KB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción: